Direct interaction between surface β1,4-galactosyltransferase 1 and epidermal growth factor receptor (EGFR) inhibits EGFR activation in hepatocellular carcinoma

Biochemical and Biophysical Research Communications

Volumn 434, Issue 3, 2013, Pages 449-454

  Tang, Wenqing ^a   Weng, Shuqiang ^a   Zhang, Si ^a   Wu, Weibing ^a   Dong, Ling ^a   Shen, Xizhong ^a   Zhang, Songwen ^a   Gu, Jianxin ^a   Xue, Ruyi ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Dimerization; EGFR; Interaction; Phosphorylation; 1,4GT1

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE 1; EPIDERMAL GROWTH FACTOR I 125; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GLYCOSYLTRANSFERASE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; EPIDERMAL GROWTH FACTOR RECEPTOR; N ACETYLLACTOSAMINE SYNTHASE; PRIMER DNA;

ARTICLE; CELL SURFACE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IN VITRO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; CONFOCAL MICROSCOPY; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROTEIN BINDING; TUMOR CELL LINE;

BASE SEQUENCE; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DNA PRIMERS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; LIVER NEOPLASMS; MICROSCOPY, CONFOCAL; N-ACETYLLACTOSAMINE SYNTHASE; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR;

MLCS; MLOWN;

EID: 84880453138     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.03.094     Document Type: Article

References (27)

1. M. Amado, R. Almeida, T. Schwientek, H. Clausen, Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions, Biochim. Biophys. Acta 1473 (1999) 35-53.
2. R.N. Russo, N.L. Shaper, J.H. Shaper, Bovine beta 1-4-galactosyltransferase: two sets of mRNA transcripts encode two forms of the protein with different amino-terminal domains. In vitro translation experiments demonstrate that both the short and the long forms of the enzyme are type II membrane-bound glycoproteins, J. Biol. Chem. 265 (1990) 3324-3331.
3. N.L. Shaper, G.F. Hollis, J.G. Douglas, I.R. Kirsch, J.H. Shaper, Characterization of the full length cDNA for murine beta-1,4-galactosyltransferase. Novel features at the 5′-end predict two translational start sites at two in-frame AUGs, J. Biol. Chem. 263 (1988) 10420-10428.
4. H.J. Hathaway, S.C. Evans, D.H. Dubois, C.I. Foote, B.H. Elder, B.D. Shur, Mutational analysis of the cytoplasmic domain of beta1,4-galactosyltransferase I: influence of phosphorylation on cell surface expression, J. Cell Sci. 116 (2003) 4319-4330.
5. P.K. Qasba, B. Ramakrishnan, E. Boeggeman, Structure and function of beta-1,4-galactosyltransferase, Curr. Drug Targets 9 (2008) 292-309.
6. S. Zhang, M. Cai, S.W. Zhang, Y. Hu, J.X. Gu, Involvement of beta 1,4 galactosyltransferase 1 and Gal beta1→4GlcNAc groups in human hepatocarcinoma cell apoptosis, Mol. Cell. Biochem. 243 (2003) 81-86.
7. Z. Li, H. Wang, H. Zong, Q. Sun, X. Kong, J. Jiang, J. Gu, Downregulation of beta1,4-galactosyltransferase 1 inhibits CDK11(p58)-mediated apoptosis induced by cycloheximide, Biochem. Biophys. Res. Commun. 327 (2005) 628-636.
8. Z. Li, H. Zong, X. Kong, S. Zhang, H. Wang, Q. Sun, J. Gu, Cell surface beta 1,4-galactosyltransferase 1 promotes apoptosis by inhibiting epidermal growth factor receptor pathway, Mol. Cell. Biochem. 291 (2006) 69-76.
9. X. Zhu, S. Chen, X. Yin, A. Shen, S. Ji, Z. Shen, J. Gu, Constitutively active PKB/Akt inhibited apoptosis and down-regulated beta 1,4-galactosyltransferase 1 in hepatocarcinoma cells, Biochem. Biophys. Res. Commun. 309 (2003) 279-285.
10. J. Shen, J. Jiang, Y. Wei, L. Zhou, D. Liu, J. Zhou, J. Gu, Two specific inhibitors of the phosphatidylinositol 3-kinase LY294002 and wortmannin up-regulate beta1,4-galactosyltransferase I and thus sensitize SMMC-7721 human hepatocarcinoma cells to cycloheximide-induced apoptosis, Mol. Cell. Biochem. 304 (2007) 361-367.
11. S.W. Zhang, S.L. Xu, M.M. Cai, J. Yan, X.Y. Zhu, Y. Hu, J.X. Gu, Effect of p58GTA on beta-1,4-galactosyltransferase 1 activity and cell-cycle in human hepatocarcinoma cells, Mol. Cell. Biochem. 221 (2001) 161-168.
12. H. Wang, M. Zhou, B. Shi, Q. Zhang, H. Jiang, Y. Sun, J. Liu, K. Zhou, M. Yao, J. Gu, S. Yang, Y. Mao, Z. Li, Identification of an exon 4-deletion variant of epidermal growth factor receptor with increased metastasis-promoting capacity, Neoplasia 13 (2011) 461-471.
13. S. Seton-Rogers, Tumorigenesis: pushing pancreatic cancer to take off, Nat. Rev. Cancer 12 (2012) 739.
14. C. Berasain, A. Nicou, O. Garcia-Irigoyen, M.U. Latasa, R. Urtasun, M. Elizalde, F. Salis, M.J. Perugorria, J. Prieto, J.A. Recio, F.J. Corrales, M.A. Avila, Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism, Dig. Dis. 30 (2012) 524-531.
15. R. Urtasun, M.U. Latasa, M.I. Demartis, S. Balzani, S. Goni, O. Garcia-Irigoyen, M. Elizalde, M. Azcona, R.M. Pascale, F. Feo, P. Bioulac-Sage, C. Balabaud, J. Muntane, J. Prieto, C. Berasain, M.A. Avila, Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation, Hepatology 54 (2012) 2149-2158.
16. S. Zhang, M. Cai, S. Zhang, S. Xu, S. Chen, X. Chen, C. Chen, J. Gu, Interaction of p58(PITSLRE), a G2/M-specific protein kinase, with cyclin D3, J. Biol. Chem. 277 (2002) 35314-35322.
17. S.L. Fitzpatrick, J. Brightwell, J.L. Wittliff, G.H. Barrows, G.S. Schultz, Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels, Cancer Res. 44 (1984) 3448-3453.
18. L.P. Sousa, I. Lax, H. Shen, S.M. Ferguson, P. De Camilli, J. Schlessinger, Suppression of EGFR endocytosis by dynamin depletion reveals that EGFR signaling occurs primarily at the plasma membrane, Proc. Natl. Acad. Sci. USA 109 (2012) 4419-4424.
19. H.J. Hathaway, Cell surface beta1,4-galactosyltransferase function in mammary gland morphogenesis: insights from transgenic and knockout mouse models, J. Mammary Gland Biol. Neoplasia 8 (2003) 421-433.
20. C.P. Coyne, M.K. Ross, J.G. Bailey, Dual potency anti-HER2/neu and anti-EGFR anthracycline immunoconjugates in chemotherapeutic-resistant mammary carcinoma combined with cyclosporin A and verapamil P-glycoprotein inhibition, J. Drug. Target. 17 (2009) 474-489.
21. M.E. Irwin, K.L. Mueller, N. Bohin, Y. Ge, J.L. Boerner, Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib, J. Cell. Physiol. 226 (2011) 2316-2328.
22. N. Li, A.R. Shaw, N. Zhang, A. Mak, L. Li, Lipid raft proteomics: analysis of insolution digest of sodium dodecyl sulfate-solubilized lipid raft proteins by liquid chromatography-matrix-assisted laser desorption/ionization tandem mass spectrometry, Proteomics 4 (2004) 3156-3166.
23. P. Fan, J. Wang, R.J. Santen, W. Yue, Long-term treatment with tamoxifen facilitates translocation of estrogen receptor alpha out of the nucleus and enhances its interaction with EGFR in MCF-7 breast cancer cells, Cancer Res. 67 (2007) 1352-1360.
24. R. Schiff, S.A. Massarweh, J. Shou, L. Bharwani, S.K. Mohsin, C.K. Osborne, Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance, Clin. Cancer Res. 10 (2004) 331S-336S.
25. A.M. Egloff, J. Grandis, Epidermal growth factor receptor-targeted molecular therapeutics for head and neck squamous cell carcinoma, Expert Opin. Ther. Targets 10 (2006) 639-647.
26. A.M. Egloff, M.E. Rothstein, R. Seethala, J.M. Siegfried, J.R. Grandis, L.P. Stabile, Cross-talk between estrogen receptor and epidermal growth factor receptor in head and neck squamous cell carcinoma, Clin. Cancer Res. 15 (2009) 6529-6540.
27. Y.C. Liu, H.Y. Yen, C.Y. Chen, C.H. Chen, P.F. Cheng, Y.H. Juan, C.H. Chen, K.H. Khoo, C.J. Yu, P.C. Yang, T.L. Hsu, C.H. Wong, Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells, Proc. Natl. Acad. Sci. USA 108 (2011) 11332-11337.